•  
  •  
 

Keywords

Early esophageal cancer, Endoscopic resection, Endoscopic mucosal resection, Endoscopic submucosal dissection

Abstract

Esophageal squamous cell carcinoma (ESCC) remains a major global health burden, particularly in East and Southeast Asia, where incidence rates are highest. Early-stage ESCC represents a critical therapeutic window in which curative treatment can be achieved using minimally invasive, organ-preserving approaches. Advances in endoscopic imaging, including narrow-band imaging, magnifying endoscopy, chromoendoscopy, and emerging modalities such as endocytoscopy and artificial intelligence–assisted detection, have substantially improved the accuracy of early diagnosis and invasion depth assessment. According to current staging systems, including the AJCC/UICC classification, endoscopic resection is an established curative treatment for carefully selected patients with mucosal ESCC. Endoscopic submucosal dissection has become the preferred technique owing to its high en bloc and R0 resection rates. This narrative review summarizes contemporary strategies for endoscopic diagnosis, patient selection, resection techniques, pathological assessment, surveillance, and future directions in the management of early ESCC.

References

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249.
2. Arnold M, Abnet CC, Neale RE, et al. Global burden of oesophageal cancer in 2018 and trends by histological subtype. Gut. 2020;69:120-127.
3. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400-412.
4. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Lymph node metastasis in superficial esophageal cancer. Dis Esophagus. 2000;13:125-129.
5. Shimada H, Nabeya Y, Matsubara H, et al. Prediction of lymph node status in superficial esophageal carcinoma: analysis of 160 surgically resected cases. Am J Surg. 2006;191:250-254.
6. Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544-551.
7. Rice TW, Ishwaran H, Hofstetter WL, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
8. Pimentel-Nunes P, Pioche M, Albéniz E, et al. Endoscopic submucosal dissection: ESGE guideline update 2022. Endoscopy. 2022;54:591-622.
9. Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20(3):343-372.
10. Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2. Esophagus. 2023;20(3):373-389.
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. Version 3.2026. Published 2026. Accessed June 15, 2026. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
12. Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1 esophageal cancer: a systematic review and meta-analysis. World J Gastroenterol. 2013;19:1424-1437.
13. Swangsri J. PS02.095: The first series of esophageal ESD for superficial squamous cell carcinoma in Thailand. Dis Esophagus. 2018;31(Sup1):148. doi:10.1093/dote/doy089.PS02.095.
14. Endoscopic Classification Review Group. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37:570-578.
15. Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the esophagus by narrow-band imaging. Gastroenterology. 2010;139:587-595.
16. Goda K, Tajiri H, Ikegami M, et al. Magnifying endoscopy with narrow-band imaging for predicting the depth of invasion in superficial esophageal squamous cell carcinoma. Endoscopy. 2009;41:531-536.
17. Inoue H, Kaga M, Ikeda H, et al. Magnification endoscopy in esophageal squamous cell carcinoma: the Japan Esophageal Society classification of intrapapillary capillary loops. Endoscopy. 2018;50:1-12.
18. Oyama T, Inoue H, Arima M, et al. Prediction of invasion depth in early esophageal squamous cell carcinoma using magnifying endoscopy with narrow-band imaging. Gastrointest Endosc. 2019;90:102-111.
19. Ishihara R, Oyama T, Abe S, et al. Risk of lymph node metastasis in superficial esophageal squamous cell carcinoma. Gastrointest Endosc. 2008;68:867-873.
20. Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Gastrointest Endosc. 2005;62:559-565.
21. Swangsri J, Nakajima Y, Kawada K, et al. Changes in the microvascular structure of mucosal squamous cell carcinoma of the esophagus and their significance in tumor progression. J Med Dent Sci. 2014;60(4):83-91.
22. Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of early esophageal neoplasia. Cancer. 1998;83:220-231.
23. Shimizu Y, Omori T, Yokoyama A, et al. Endoscopic diagnosis of early esophageal cancer using the pink color sign after Lugol chromoendoscopy. Gastrointest Endosc. 2008;68:432-438.
24. Kondo H, Yamada K, Watanabe H, et al. Diagnostic usefulness of the pink color sign for esophageal squamous cell carcinoma. Endoscopy. 2019;51:1-8.
25. Puli SR, Reddy JB, Bechtold ML, Antillon MR, Ibdah JA, Antillon D. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis. World J Gastroenterol. 2008;14:1479-1490.
26. Minami H, Inoue H, Ikeda H, et al. Usefulness of endocytoscopy for the diagnosis of esophageal squamous cell carcinoma. Gastrointest Endosc. 2017;85:933-942.
27. Guo L, Xiao X, Wu C, et al. Real-time automated diagnosis of early esophageal squamous cell carcinoma using endoscopic images. Gut. 2020;69:2168-2179.
28. Yoshida S, Miyasaka K, Yonekura Y, Fukuda K, Abe S. Comparison of the Efficacy and Safety of General Anesthesia and Sedation Management for Esophageal Endoscopic Submucosal Dissection: A Retrospective Study. JMA J. 2026;9(3):635-642.
29. Katada C, Muto M, Manabe T, Ohtsu A, Yoshida S. Local recurrence of squamous cell carcinoma of the esophagus after EMR. Gastrointest Endosc. 2003;57:165-169.
30. Zhao Y, Yin Y, Hu Y, et al. Endoscopic submucosal dissection versus endoscopic mucosal resection for early esophageal cancer: a meta-analysis. Endoscopy. 2020;52:921-932.
31. Min YW, Lee JH, Kim JJ, et al. Long-term outcomes of endoscopic submucosal dissection for early esophageal squamous cell carcinoma. Gastrointest Endosc. 2021;93:120-130.
32. Yamaguchi N, Isomoto H, Nakayama T, et al. Steroid therapy for prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc. 2020;92:111-120.
33. Isomoto H, Yamaguchi N, Minami H, Nakao K. Management of complications associated with endoscopic submucosal dissection/endoscopic mucosal resection for esophageal cancer. Dig Endosc. 2013;25(Suppl 1):29-38.

Download

Share

COinS